Labiotech recently published an article written by Willow Shah-Neville, exploring the trends set to shape the biotech industry in 2025. From AI-powered drug discovery to personalised medicine and the rise of mergers and acquisitions, the piece highlights how the industry continues to innovate and adapt to new challenges.
LongeVC’s partner, Artem Trotsyuk, also shared his thoughts on a growing trend: larger and medium-sized companies acquiring smaller biotechs to access new medicines and cutting-edge technologies. As older drug patents expire, this approach allows companies to stay ahead in a competitive market.
The article provides a thoughtful overview of the developments shaping biotech’s future and offers insights into how these trends will impact healthcare and innovation in the coming year.
To read more about the trends influencing biotech, check out the full Labiotech article here.
LongeVC’s partner, Artem Trotsyuk, also shared his thoughts on a growing trend: larger and medium-sized companies acquiring smaller biotechs to access new medicines and cutting-edge technologies. As older drug patents expire, this approach allows companies to stay ahead in a competitive market.
The article provides a thoughtful overview of the developments shaping biotech’s future and offers insights into how these trends will impact healthcare and innovation in the coming year.
To read more about the trends influencing biotech, check out the full Labiotech article here.